Treatment of Peyronie's disease with intralesional verapamil injection.

[1]  A. Melman,et al.  Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. , 1998, Urology.

[2]  R. Clayman,et al.  Ureteral cell cultures II: Collagen production and response to pharmacologic agents. , 1996, The Journal of urology.

[3]  P. Erne,et al.  Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. Stetler-Stevenson.  Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. , 1996, The American journal of pathology.

[5]  L. Levine,et al.  Penile vascular assessment using color duplex sonography in men with Peyronie's disease. , 1996, Journal of Urology.

[6]  M. Nauck,et al.  Ca2+-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells , 1995 .

[7]  T. Lue,et al.  Is colchicine effective in Peyronie's disease? A pilot study. , 1994, Urology.

[8]  Raphael C. Lee,et al.  Intralesional verapamil injection for the treatment of Peyronie's disease. , 1994, The Journal of urology.

[9]  A. Jellema,et al.  The response of burn scars to intralesional verapamil. Report of five cases. , 1994, Archives of surgery.

[10]  F. Dorey,et al.  Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study. , 1993, The Journal of urology.

[11]  G. Bottazzo,et al.  The treatment of Peyronie's disease with tamoxifen. , 1992, British journal of urology.

[12]  G. Schubert.  Anatomy and pathophysiology of Peyronie's disease and congenital deviation of the penis. , 1991, Urologia internationalis.

[13]  F. Dorey,et al.  The natural history of Peyronie's disease. , 1990, The Journal of urology.

[14]  Raphael C Lee,et al.  Calcium antagonists retard extracellular matrix production in connective tissue equivalent. , 1990, The Journal of surgical research.

[15]  Mazo Ve.  [A new method for treating Peyronie's disease]. , 1989 .

[16]  J. Vergés,et al.  [New therapy for Peyronie's disease: superoxide dismutase by ionization. Comparison with an earlier classical series]. , 1988, Annales d'Urologie.

[17]  R. Kelly.  Pathways of protein secretion in eukaryotes. , 1985, Science.

[18]  J. Kaufman,et al.  The use of collagenase in the treatment of Peyronie's disease. , 1985, The Journal of urology.

[19]  Z. Werb,et al.  Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts , 1984, The Journal of cell biology.

[20]  A. Kelâmi.  Classification of congenital and acquired penile deviation. , 1983, Urologia internationalis.

[21]  G. Bartsch,et al.  Orgotein, a new drug for the treatment of Peyronie's disease. , 1981, European journal of rheumatology and inflammation.

[22]  H. Gustafson,et al.  Peyronie's disease: experience of local treatment with Orgotein. , 1981, European urology.

[23]  G. Williams,et al.  The non-surgical treatment of Peyronie's disease. , 1980, British journal of urology.

[24]  R. Hasche-Klünder.  [Treatment of peyronie's disease with para-aminobenzoacidic potassium (POTOBA) (author's transl)]. , 1978, Der Urologe (Ausg. A).

[25]  R. Morgan,et al.  Procarbazine (Natulan) in the treatment of Peyronie's disease. , 1978, British journal of urology.

[26]  L. Hovelius,et al.  Report of Five Cases , 1977 .

[27]  A. Morales,et al.  The treatment of Peyronie's disease with parathyroid hormone. , 1975, The Journal of urology.

[28]  R. Khanna,et al.  Peyronie's disease: results with dermo-jet injection of dexamethasone. , 1975, The Journal of urology.

[29]  W. Oosterlinck,et al.  Treatment of Peyronie's disease with procarbazine. , 1975, British journal of urology.

[30]  I. N. Frank,et al.  The ultrasonic treatment of Peyronie's disease. , 1971, The Journal of urology.

[31]  C. Zarafonetis,et al.  Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba). , 1959, The Journal of urology.

[32]  H. Bodner,et al.  Peyronie’s Disease: Cortisone-Hyaluronidase-Hydro-Cortisone Therapy , 1954 .

[33]  G. H. Teasley.  Peyronie’s Disease: A New Approach , 1954 .

[34]  Scott Ww,et al.  A new concept in the treatment of Peyronie's disease. , 1948 .